Enliven Therapeutics, Inc. Share Price
NASDAQ: ELVN | Mid CapEnliven Therapeutics, Inc. Stock Performance
Open $60.40 | Prev. Close $60.42 | Circuit Range N/A |
Day Range $59.81 - $61.63 | Year Range $14.84 - $61.63 | Volume 18,309 |
Average Traded $60.46 |
Enliven Therapeutics, Inc. Share Price Today
As of 9 August 2026, Enliven Therapeutics, Inc.'s share price is $60.30. The stock opened at $60.40, compared to its previous close of $60.42. During today's trading session, Enliven Therapeutics, Inc.'s share price traded between $59.81 and $61.63, with an average price of $60.72. Over the past 52 weeks, the stock has recorded a high of $61.63 and a low of $14.84. In terms of performance, Enliven Therapeutics, Inc.'s share price has risen by 103.10% over the last six months and is up 197.92% on a year-on-year basis.
Enliven Therapeutics, Inc. Share Price Chart
Enliven Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $3.42B | PE Ratio (TTM) -32.95 | Dividend Yield N/A |
EPS (TTM) $-1.83 | Revenue (TTM) N/A | Return On Equity (TTM) -22.56% |
Profit Margin N/A | Debt to Equity 0.04 | Quarterly Earnings Growth YoY 12.99% |
Enliven Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Enliven Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.
Enliven Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $53.50 | $60.23 | +9.97% |
Jul 2026 | $51.27 | $54.77 | +7.92% |
Jun 2026 | $38.73 | $50.75 | +28.14% |
May 2026 | $40.73 | $39.60 | -4.00% |
Apr 2026 | $39.57 | $41.26 | +5.43% |
Mar 2026 | $29.48 | $39.13 | +31.80% |
Feb 2026 | $26.25 | $29.69 | +12.00% |
Jan 2026 | $15.34 | $26.51 | +72.25% |
Dec 2025 | $20.78 | $15.39 | -28.75% |
Nov 2025 | $22.66 | $21.60 | -7.85% |
Oct 2025 | $20.45 | $23.44 | +14.40% |
Sep 2025 | $21.13 | $20.49 | +1.24% |
ELVN Share Price FAQs
What is Enliven Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Enliven Therapeutics, Inc. stock?
What is ELVN's market capitalisation today?
What is ELVN's net income for the last quarter?
What is the 5 year returns of ELVN?
What is the high & low stock price of ELVN today?
Can I buy ELVN shares in India?